{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:15:39Z","timestamp":1782494139513,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10620-022-07756-6","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T02:02:47Z","timestamp":1668564167000},"page":"2107-2114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of Undiagnosed Acute Hepatic Porphyria in Cyclic Vomiting Syndrome and Overlap in Clinical Symptoms"],"prefix":"10.1007","volume":"68","author":[{"given":"Shanna","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuping","family":"Garacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika L.","family":"Erwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-7456","authenticated-orcid":false,"given":"Thangam","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"7756_CR1","unstructured":"Anderson KE BD, Desnick RJ. Scriver CR, B.A., Sly WS, et al. Disorders of heme biosynthesis: X-linked sideroblastic anemias and the porphyrias. In The Metabolic and Molecular Basis of Inherited Disease. Ed.; McGraw-Hill: New York, NY:2991\u20133062."},{"key":"7756_CR2","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/humu.23067","volume":"37","author":"B Chen","year":"2016","unstructured":"Chen B, Solis-Villa C, Hakenberg J et al. Acute Intermittent Porphyria: Predicted Pathogenicity of HMBS Variants Indicates Extremely Low Penetrance of the Autosomal Dominant Disease. Hum Mutat 2016;37:1215\u20131222.","journal-title":"Hum Mutat"},{"key":"7756_CR3","doi-asserted-by":"crossref","unstructured":"Meissner P, Adams P, Kirsch R. Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria. J Clin Invest 1993;91:1436\u201344.","DOI":"10.1172\/JCI116348"},{"key":"7756_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1055\/s-2008-1040701","volume":"2","author":"HL Bonkowsky","year":"1982","unstructured":"Bonkowsky HL, Schady W. Neurologic manifestations of acute porphyria. Semin Liver Dis 1982;2:108\u2013124.","journal-title":"Semin Liver Dis"},{"key":"7756_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ymgme.2019.07.002","volume":"128","author":"KE Anderson","year":"2019","unstructured":"Anderson KE. Acute hepatic porphyrias: Current diagnosis & management. Mol Genet Metab 2019;128:219\u2013227.","journal-title":"Mol Genet Metab"},{"key":"7756_CR6","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","volume":"127","author":"HL Bonkovsky","year":"2014","unstructured":"Bonkovsky HL, Maddukuri VC, Yazici C et al. Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium. Am J Med 2014;127:1233\u20131241.","journal-title":"Am J Med"},{"key":"7756_CR7","doi-asserted-by":"crossref","unstructured":"Andersson C, Innala E, Backstrom T. Acute intermittent porphyria in women: clinical expression, use and experience of exogenous sex hormones. A population-based study in northern Sweden. J Intern Med 2003;254:176\u201383.","DOI":"10.1046\/j.1365-2796.2003.01172.x"},{"key":"7756_CR8","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","volume":"150","author":"V Stanghellini","year":"2016","unstructured":"Stanghellini V, Chan FKL, Hasler WL et al. Gastroduodenal disorders. Gastroenterology 2016;150:1380\u20131392.","journal-title":"Gastroenterology"},{"key":"7756_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-230X-12-52","volume":"12","author":"N Kumar","year":"2012","unstructured":"Kumar N, Bashar Q, Reddy N et al. Cyclic Vomiting Syndrome (CVS): is there a difference based on onset of symptoms\u2013pediatric versus adult? BMC Gastroenterol 2012;12:52.","journal-title":"BMC Gastroenterol"},{"issue":"Suppl 2","key":"7756_CR10","volume":"31","author":"T Venkatesan","year":"2019","unstructured":"Venkatesan T, Levinthal DJ, Tarbell SE et al. Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association. Neurogastroenterol Motil 2019;31:e13604.","journal-title":"Neurogastroenterol Motil"},{"key":"7756_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000510933","volume":"15","author":"A Carpenter","year":"2021","unstructured":"Carpenter A, Levinthal DJ, Binion DG et al. Improvement of Cyclic Vomiting Syndrome with Outpatient Ketamine Infusions. Case Rep Gastroenterol 2021;15:9\u201316.","journal-title":"Case Rep Gastroenterol"},{"key":"7756_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1741-7015-3-20","volume":"3","author":"DR Fleisher","year":"2005","unstructured":"Fleisher DR, Gornowicz B, Adams K et al. Cyclic Vomiting Syndrome in 41 adults: the illness, the patients, and problems of management. BMC Med 2005;3:20.","journal-title":"BMC Med"},{"key":"7756_CR13","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/archinte.1990.00390190115018","volume":"150","author":"KE Anderson","year":"1990","unstructured":"Anderson KE, Spitz IM, Bardin CW et al. A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria. Arch Intern Med 1990;150:1469\u20131474.","journal-title":"Arch Intern Med"},{"key":"7756_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2982.2008.01113.x","volume":"20","author":"TL Abell","year":"2008","unstructured":"Abell TL, Adams KA, Boles RG et al. Cyclic vomiting syndrome in adults. Neurogastroenterol Motil 2008;20:269\u2013284.","journal-title":"Neurogastroenterol Motil"},{"issue":"Pt 6","key":"7756_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1177\/000456329803500604","volume":"35","author":"AC Deacon","year":"1998","unstructured":"Deacon AC, Peters TJ. Identification of acute porphyria: evaluation of a commercial screening test for urinary porphobilinogen. Ann Clin Biochem 1998;35:726\u2013732.","journal-title":"Ann Clin Biochem"},{"key":"7756_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1358\/dot.2021.57.1.3230207","volume":"57","author":"A Honor","year":"2021","unstructured":"Honor A, Rudnick SR, Bonkovsky HL. Givosiran to treat acute porphyria. Drugs Today (Barc) 2021;57:47\u201359.","journal-title":"Drugs Today (Barc)"},{"key":"7756_CR17","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa1913147","volume":"382","author":"M Balwani","year":"2020","unstructured":"Balwani M, Sardh E, Ventura P et al. Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria. N Engl J Med 2020;382:2289\u20132301.","journal-title":"N Engl J Med"},{"key":"7756_CR18","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cgh.2018.05.020","volume":"17","author":"I Aziz","year":"2019","unstructured":"Aziz I, Palsson OS, Whitehead WE et al. Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults. Clin Gastroenterol Hepatol 2019;17:878\u2013886.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7756_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14218\/JCTH.2014.00039","volume":"3","author":"DM Bissell","year":"2015","unstructured":"Bissell DM, Wang B. Acute Hepatic Porphyria. J Clin Transl Hepatol 2015;3:17\u201326.","journal-title":"J Clin Transl Hepatol"},{"key":"7756_CR20","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s00415-008-0779-9","volume":"255","author":"E Pischik","year":"2008","unstructured":"Pischik E, Kazakov V, Kauppinen R. Is screening for urinary porphobilinogen useful among patients with acute polyneuropathy or encephalopathy? J Neurol 2008;255:974\u2013979.","journal-title":"J Neurol"},{"issue":"Suppl 2","key":"7756_CR21","volume":"31","author":"WL Hasler","year":"2019","unstructured":"Hasler WL, Levinthal DJ, Tarbell SE et al. Cyclic vomiting syndrome: Pathophysiology, comorbidities, and future research directions. Neurogastroenterol Motil 2019;31:e13607.","journal-title":"Neurogastroenterol Motil"},{"key":"7756_CR22","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00221-014-3939-4","volume":"232","author":"DJ Levinthal","year":"2014","unstructured":"Levinthal DJ, Bielefeldt K. Adult cyclical vomiting syndrome: a disorder of allostatic regulation? Exp Brain Res 2014;232:2541\u20132547.","journal-title":"Exp Brain Res"},{"key":"7756_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11894-018-0654-5","volume":"20","author":"K Kovacic","year":"2018","unstructured":"Kovacic K, Sood M, Venkatesan T. Cyclic Vomiting Syndrome in Children and Adults: What Is New in 2018? Curr Gastroenterol Rep 2018;20:46.","journal-title":"Curr Gastroenterol Rep"},{"key":"7756_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-227X-10-4","volume":"10","author":"T Venkatesan","year":"2010","unstructured":"Venkatesan T, Tarbell S, Adams K et al. A survey of emergency department use in patients with cyclic vomiting syndrome. BMC Emerg Med 2010;10:4.","journal-title":"BMC Emerg Med"},{"key":"7756_CR25","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1111\/j.1572-0241.2007.01549.x","volume":"102","author":"N Pareek","year":"2007","unstructured":"Pareek N, Fleisher DR, Abell T. Cyclic vomiting syndrome: what a gastroenterologist needs to know. Am J Gastroenterol 2007;102:2832\u20132840.","journal-title":"Am J Gastroenterol"},{"key":"7756_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0065-3101(23)00096-8","volume":"47","author":"BU Li","year":"2000","unstructured":"Li BU, Balint JP. Cyclic vomiting syndrome: evolution in our understanding of a brain-gut disorder. Adv Pediatr 2000;47:117\u2013160.","journal-title":"Adv Pediatr"},{"key":"7756_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0022-3476(99)70242-8","volume":"134","author":"BU Li","year":"1999","unstructured":"Li BU, Murray RD, Heitlinger LA et al. Is cyclic vomiting syndrome related to migraine? J Pediatr 1999;134:567\u2013572.","journal-title":"J Pediatr"},{"key":"7756_CR28","doi-asserted-by":"crossref","unstructured":"Partovi O, Patel M, Cheng S et al. 331: Clinical characteristics and long-term outcomes in patients with cyclic vomiting syndrome. Gastroenterology 2022;162:S-69\u2013S-70.","DOI":"10.1016\/S0016-5085(22)60171-9"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07756-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07756-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07756-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T07:59:03Z","timestamp":1728374343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07756-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["7756"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07756-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"5 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TV is a consultant for Takeda Pharmaceuticals and has consulted for Alnylam Pharmaceuticals and Alexza Pharmaceuticals. ALE is a speaker and consultant for Alnylam Pharmaceuticals and has consulted for Mitsubishi Tanabe Pharma and Disc Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}